Pharmaceutical composition for preventing or treating liver diseases, containing plasmalogen precursor, plasmalogen or plasmalogen analog as effective component

作者: Eun Hee Koh , Jung Eun Jang , Ki Up Lee

DOI:

关键词:

摘要:

参考文章(8)
Dayan Goodenowe, Pearson Ahiahonu, M. Amin Khan, Paul L. Wood, Rishikesh Mankidy, Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging ,(2009)
Itzhak Mendel, Gideon Halperin, Jacob George, Dror Harats, Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders ,(2004)
Nancy E. Braverman, Ann B. Moser, Functions of plasmalogen lipids in health and disease. Biochimica et Biophysica Acta. ,vol. 1822, pp. 1442- 1452 ,(2012) , 10.1016/J.BBADIS.2012.05.008
P. Tessari, A. Coracina, A. Cosma, A. Tiengo, Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutrition Metabolism and Cardiovascular Diseases. ,vol. 19, pp. 291- 302 ,(2009) , 10.1016/J.NUMECD.2008.12.015
Mingshun Zhang, Shuna Sun, Ning Tang, Wei Cai, Linxi Qian, Oral Administration of Alkylglycerols Differentially Modulates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice Evidence-based Complementary and Alternative Medicine. ,vol. 2013, pp. 834027- 834027 ,(2013) , 10.1155/2013/834027
Elisa Fabbrini, Shelby Sullivan, Samuel Klein, Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic and Clinical Implications Hepatology. ,vol. 51, pp. 679- 689 ,(2010) , 10.1002/HEP.23280